Article
Single-nucleotide polymorphisms studied for associations with urinary toxicity from (125)I prostate brachytherapy implants.
Brachytherapy - 1 Jan 2000
Usmani Nawaid, Leong Nelson, Martell Kevin, Lan Lanna, Ghosh Sunita, Pervez Nadeem, Pedersen John, Yee Don, Murtha Albert, Amanie John, Sloboda Ron, Murray David, Parliament Matthew
Abstract excerpt
PURPOSE: To identify clinical, dosimetric, and genetic factors that are associated with late urinary toxicity after a (125)I prostate brachytherapy implant. METHODS AND MATERIALS: Genomic DNA from 296 men treated with (125)I prostate brachytherapy monotherapy was extracted from saliva samples for this study. A retrospective database was compiled including clinical, dosimetric, and toxicity data for this cohort of...
Topics
Join the communities discussing this publication.
